
Recent cancer studies emphasize that genetic and zzso zzso changes drive the evolutionary rate of cancer progression and drug zzso We discuss the ways in which zzso aspects of cellular zzso may significantly increase evolutionary zzso zzso zzso arises by zzso fluctuations in cells and by zzso responses of cells to the zzso New approaches to drug design may be required to control zzso zzso and the evolution of resistance to zzso 

